Login / Signup

Effects of pimobendan in cats with hypertrophic cardiomyopathy and recent congestive heart failure: Results of a prospective, double-blind, randomized, nonpivotal, exploratory field study.

Karsten E SchoberJohn E RushVirginia Luis FuentesTony GlausNuala J SummerfieldKathy N WrightLinda LehmkuhlGerhard WessMargaret P SayerJoao LoureiroJohn MacGregorNicole Mohren
Published in: Journal of veterinary internal medicine (2021)
In this study of cats with HCM and recent CHF, no benefit of pimobendan on 180-day outcome was identified.
Keyphrases
  • hypertrophic cardiomyopathy
  • double blind
  • heart failure
  • left ventricular
  • placebo controlled
  • clinical trial
  • open label
  • phase iii
  • phase ii
  • study protocol